Extreme Events and Cascading Hazards
ID: 9.1Type: Phase I
Overview

Topic

Extreme Events and Cascading Hazards

Agency

Department of CommerceNational Oceanic and Atmospheric Administration

Program

Type: SBIRPhase: Phase IYear: 2024
Timeline
  1. 1
    Release Sep 28, 2023 12:00 AM
  2. 2
    Open Sep 28, 2023 12:00 AM
  3. 3
    Next Submission Due Dec 20, 2023 12:00 AM
  4. 4
    Close Dec 20, 2023 12:00 AM
Description

The Department of Commerce is seeking proposals for the NOAA FY 2024 Small Business Innovation Research Phase I program. The specific topic of the solicitation is "Extreme Events and Cascading Hazards". This research aims to address the enduring risks faced by communities, particularly underserved ones, from extreme weather, water, and climate events. The goal is to develop innovative solutions that mitigate the impact of these events on key sectors of the economy, such as transportation, power generation, agriculture, recreation, and natural resource management. The research topics include preparing for and adapting to extreme events, understanding risk, supporting wildfire detection and monitoring, drought early warnings, equitable access to information, modeling urban heat island effects, and supporting STEM education. The Phase I program has a project duration of one year and offers funding for small businesses to develop and demonstrate the feasibility of their proposed solutions. The application due date for this solicitation is December 20, 2023. For more information, visit the SBIR topic link here or the solicitation agency URL here.

Files
No associated files provided.
Similar Opportunities
DOD SBIR 24.4 Annual - Large Scale Mobilization Operations Analysis
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the topic of "Large Scale Mobilization Operations Analysis" as part of their SBIR program. The U.S. Army Reserve (USAR) is looking to identify challenges and create efficiencies in the mobilization process to better support combatant commanders during Large-Scale Combat Operations (LSCO) through Large Scale Mobilization Operations (LSMO). The goal is to enhance the mobilization process, increase overall readiness, and support combatant commanders. The program will also share findings with Army National Guard partners. Proposals can be submitted for both Phase I and Phase II, with Phase II proposals requiring documentation to substantiate scientific and technical merit. The technology has potential applications in supply chain forecasting, weather risk intelligence, and banking and financing. The solicitation is open until March 31, 2025. For more information, visit the [solicitation link](https://www.sbir.gov/node/2496857).
DOD SBIR 24.4 Annual - Atmospheric Water Extraction Plus (AWE+)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the topic "Atmospheric Water Extraction Plus (AWE+)" as part of its SBIR program. The objective of this solicitation is to develop novel atmospheric water extraction technology with potential for energy use below 100Wh electric per liter of water generated across a wide range of environments. The technology should be integrated into a proof-of-concept prototype producing potable water with a clear path to full-size implementation. The DOD has a critical need to reduce water resupply requirements for mobile and self-sufficient operations. The development of AWE+ technology will have important tactical implications, reducing casualties and costs in forward operating environments. The goal is to provide potable water for a range of military needs by developing low-power, distributable systems that can provide water anywhere, anytime, and without the need for any external liquid water source. DARPA, the Defense Advanced Research Projects Agency, is specifically seeking teams with innovative means of releasing water from sorbents which is cyclically stable and has very low energy requirements. The technology should be able to produce water with not more than 100Wh electricity per liter of water produced, and not more than 100Wh thermal energy per liter of water produced. Proposals should outline a plan for reaching these energy metrics and provide an estimate for the range of environmental conditions at which the devices could operate. The project will be conducted in two phases. Phase I is a six-month effort focusing on proof-of-concept material and release mechanism development. Phase II is a 24-month effort with a base period of nine months, followed by two option periods. The performers will be expected to demonstrate functionality of their water capture and release mechanisms in a laboratory environment, producing at least 100mL of potable liquid water over a six-hour period with minimal loss in performance. The ultimate goal of this effort is to demonstrate AWE capable of meeting potable water needs for expeditionary scenarios with extremely high efficiency. Phase III will focus on transition within the DoD/military and further commercialization of the technology. Potential applications include satisfying military expeditionary water needs, reducing logistical footprint and vulnerability of supply lines, and developing next-generation dehumidification systems for residential and commercial HVAC. Keywords: Atmospheric water extraction, atmospheric water capture, atmospheric water harvesting, sorbent materials, advanced manufacturing. For more information and to submit proposals, visit the DOD SBIR 24.4 Annual solicitation notice on grants.gov or the DOD SBIR/STTR Opportunities website. The open date for proposals is October 3, 2023, and the close date is March 31, 2025.
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/pa-files/PAR-24-044.html).
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) topic. This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The solicitation is open until September 6, 2026, and more information can be found at the provided links.